Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 171

1.

Robust genomic copy number predictor of pan cancer metastasis.

Pearlman A, Upadhyay K, Cole K, Loke J, Sun K, Fineberg S, Freedland SJ, Shao Y, Ostrer H.

Genes Cancer. 2018 Jan;9(1-2):66-77. doi: 10.18632/genesandcancer.165.

2.

High-depth whole genome sequencing of an Ashkenazi Jewish reference panel: enhancing sensitivity, accuracy, and imputation.

Lencz T, Yu J, Palmer C, Carmi S, Ben-Avraham D, Barzilai N, Bressman S, Darvasi A, Cho JH, Clark LN, Gümüş ZH, Joseph V, Klein R, Lipkin S, Offit K, Ostrer H, Ozelius LJ, Peter I, Atzmon G, Pe'er I.

Hum Genet. 2018 Apr;137(4):343-355. doi: 10.1007/s00439-018-1886-z. Epub 2018 Apr 28.

PMID:
29705978
3.

Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy.

Lee S, Kerns S, Ostrer H, Rosenstein B, Deasy JO, Oh JH.

Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):128-135. doi: 10.1016/j.ijrobp.2018.01.054. Epub 2018 Jan 31.

PMID:
29502932
4.

Functional variants in the LRRK2 gene confer shared effects on risk for Crohn's disease and Parkinson's disease.

Hui KY, Fernandez-Hernandez H, Hu J, Schaffner A, Pankratz N, Hsu NY, Chuang LS, Carmi S, Villaverde N, Li X, Rivas M, Levine AP, Bao X, Labrias PR, Haritunians T, Ruane D, Gettler K, Chen E, Li D, Schiff ER, Pontikos N, Barzilai N, Brant SR, Bressman S, Cheifetz AS, Clark LN, Daly MJ, Desnick RJ, Duerr RH, Katz S, Lencz T, Myers RH, Ostrer H, Ozelius L, Payami H, Peter Y, Rioux JD, Segal AW, Scott WK, Silverberg MS, Vance JM, Ubarretxena-Belandia I, Foroud T, Atzmon G, Pe'er I, Ioannou Y, McGovern DPB, Yue Z, Schadt EE, Cho JH, Peter I.

Sci Transl Med. 2018 Jan 10;10(423). pii: eaai7795. doi: 10.1126/scitranslmed.aai7795.

PMID:
29321258
5.

Biallelic mutations in FLNB cause a skeletal dysplasia with 46,XY gonadal dysgenesis by activating β-catenin.

Upadhyay K, Loke J, O V, Taragin B, Ostrer H.

Clin Genet. 2018 Feb;93(2):412-416. doi: 10.1111/cge.13165. Epub 2017 Dec 26.

PMID:
29095481
6.

Assessing risk for Mendelian disorders in a Bronx population.

diSibio G, Upadhyay K, Meyer P, Oddoux C, Ostrer H.

Mol Genet Genomic Med. 2017 Jul 6;5(5):516-523. doi: 10.1002/mgg3.307. eCollection 2017 Sep.

7.

MAP3K1-related gonadal dysgenesis: Six new cases and review of the literature.

Granados A, Alaniz VI, Mohnach L, Barseghyan H, Vilain E, Ostrer H, Quint EH, Chen M, Keegan CE.

Am J Med Genet C Semin Med Genet. 2017 Jun;175(2):253-259. doi: 10.1002/ajmg.c.31559. Epub 2017 May 15.

PMID:
28504475
8.

Differential analysis of mutations in the Jewish population and their implications for diseases.

Einhorn Y, Weissglas-Volkov D, Carmi S, Ostrer H, Friedman E, Shomron N.

Genet Res (Camb). 2017 May 15;99:e3. doi: 10.1017/S0016672317000015.

PMID:
28502252
9.

Prediction of breast cancer risk based on flow-variant analysis of circulating peripheral blood B cells.

Syeda MM, Upadhyay K, Loke J, Pearlman A, Klugman S, Shao Y, Ostrer H.

Genet Med. 2017 Sep;19(9):1071-1077. doi: 10.1038/gim.2016.222. Epub 2017 Mar 16.

PMID:
28301456
10.

Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes.

Oh JH, Kerns S, Ostrer H, Powell SN, Rosenstein B, Deasy JO.

Sci Rep. 2017 Feb 24;7:43381. doi: 10.1038/srep43381.

11.

Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.

Kerns SL, Dorling L, Fachal L, Bentzen S, Pharoah PD, Barnes DR, Gómez-Caamaño A, Carballo AM, Dearnaley DP, Peleteiro P, Gulliford SL, Hall E, Michailidou K, Carracedo Á, Sia M, Stock R, Stone NN, Sydes MR, Tyrer JP, Ahmed S, Parliament M, Ostrer H, Rosenstein BS, Vega A, Burnet NG, Dunning AM, Barnett GC, West CM; Radiogenomics Consortium.

EBioMedicine. 2016 Aug;10:150-63. doi: 10.1016/j.ebiom.2016.07.022. Epub 2016 Jul 20.

12.

Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients.

Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CML, Burnet NG, Elliott R, Coles C, Hall E, Fachal L, Vega A, Gómez-Caamaño A, Talbot CJ, Symonds RP, De Ruyck K, Thierens H, Ost P, Chang-Claude J, Seibold P, Popanda O, Overgaard M, Dearnaley D, Sydes MR, Azria D, Koch CA, Parliament M, Blackshaw M, Sia M, Fuentes-Raspall MJ, Ramon Y Cajal T, Barnadas A, Vesprini D, Gutiérrez-Enríquez S, Mollà M, Díez O, Yarnold JR, Overgaard J, Bentzen SM, Alsner J; International Radiogenomics Consortium (RgC).

Radiother Oncol. 2016 Dec;121(3):431-439. doi: 10.1016/j.radonc.2016.06.017. Epub 2016 Jul 18.

13.

The genetic history of Cochin Jews from India.

Waldman YY, Biddanda A, Dubrovsky M, Campbell CL, Oddoux C, Friedman E, Atzmon G, Halperin E, Ostrer H, Keinan A.

Hum Genet. 2016 Oct;135(10):1127-43. doi: 10.1007/s00439-016-1698-y. Epub 2016 Jul 4.

14.

The Genetics of Bene Israel from India Reveals Both Substantial Jewish and Indian Ancestry.

Waldman YY, Biddanda A, Davidson NR, Billing-Ross P, Dubrovsky M, Campbell CL, Oddoux C, Friedman E, Atzmon G, Halperin E, Ostrer H, Keinan A.

PLoS One. 2016 Mar 24;11(3):e0152056. doi: 10.1371/journal.pone.0152056. eCollection 2016.

15.

How Will Big Data Improve Clinical and Basic Research in Radiation Therapy?

Rosenstein BS, Capala J, Efstathiou JA, Hammerbacher J, Kerns SL, Kong FS, Ostrer H, Prior FW, Vikram B, Wong J, Xiao Y.

Int J Radiat Oncol Biol Phys. 2016 Jul 1;95(3):895-904. doi: 10.1016/j.ijrobp.2015.11.009. Epub 2015 Nov 11. No abstract available.

16.

Response to Zlotogora and Meiner.

Baskovich B, Hiraki S, Oddoux C, Ostrer H, Upadhyay K.

Genet Med. 2016 May;18(5):530. doi: 10.1038/gim.2015.170. Epub 2015 Dec 10. No abstract available.

PMID:
26656652
17.

The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention.

Kerns SL, Kundu S, Oh JH, Singhal SK, Janelsins M, Travis LB, Deasy JO, Janssens AC, Ostrer H, Parliament M, Usmani N, Rosenstein BS.

Semin Radiat Oncol. 2015 Oct;25(4):281-91. doi: 10.1016/j.semradonc.2015.05.006. Epub 2015 May 15. Review.

18.

Expanded genetic screening panel for the Ashkenazi Jewish population.

Baskovich B, Hiraki S, Upadhyay K, Meyer P, Carmi S, Barzilai N, Darvasi A, Ozelius L, Peter I, Cho JH, Atzmon G, Clark L, Yu J, Lencz T, Pe'er I, Ostrer H, Oddoux C.

Genet Med. 2016 May;18(5):522-8. doi: 10.1038/gim.2015.123. Epub 2015 Sep 3.

19.

The origin of the p.E180 growth hormone receptor gene mutation.

Ostrer H.

Growth Horm IGF Res. 2016 Jun;28:51-2. doi: 10.1016/j.ghir.2015.08.003. Epub 2015 Aug 7.

PMID:
26277320
20.

Functional variant analyses (FVAs) predict pathogenicity in the BRCA1 DNA double-strand break repair pathway.

Loke J, Pearlman A, Upadhyay K, Tesfa L, Shao Y, Ostrer H.

Hum Mol Genet. 2015 Jun 1;24(11):3030-7. doi: 10.1093/hmg/ddv048. Epub 2015 Feb 4.

PMID:
25652403

Supplemental Content

Loading ...
Support Center